Skip to content
  • News & Events
  • Resources
  • Worldwide
    • United States
    • French
    • Spanish
  • Discover SUDOSCAN
  • FAQ
  • Patients Information
Request a demo
Contact us
  • SUDOSCAN
    • Discover SUDOSCAN
    • Discover Sudocloud RPM
    • FAQ
    • Patients Information
  • THERAPEUTIC AREAS
    TERMS (3)
    Diabetes

    SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.

    Picto-Neurology
    Neurology

    Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.

    Picto-Oncology
    Oncology

    SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).

    Nephrology

    SUDOSCAN has demonstrated its clinical utility in Nephrology.

    Picto-Follow-up
    Follow-up

    A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.

    Diabetes Risk

    Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score

    • SUDOSCAN and Diabetes
    • SUDOSCAN in Neurology
    • SUDOSCAN in Oncology
    • SUDOSCAN in Nephrology
    • Follow-up with SUDOSCAN
    • Diabetes Risk with EZSCAN
  • SCIENCE & RESEARCH
    • SUDOSCAN Publications
    • Scientific references worldwide
    • Scientific news
    • Webinars & Replays
    • Join Clinical Research
    • Subscribe to our Scientific News
  • WHO WE ARE
    • About Impeto Medical
    • Impeto Medical in the World
Contact us

Scientific news

Scientific news

Home » SCIENCE & RESEARCH » Scientific news
Scientific newsSebastien2026-05-28T14:23:22+00:00
  • Neurological diseasesScientific publications

    SUDOSCAN in autoimmune small fiber neuropathy

    SUDOSCAN in autoimmune small fiber neuropathy

    May 19, 2021
    Visuel-spot-sudoscan-autoimune-SFN
  • Visuel article Sudoscan Oncology

    Oncology / Scientific publications

    SUDOSCAN in Oncology : Chemotherapy Induced Polyneuropathy

    SUDOSCAN in Oncology : Chemotherapy InduCed Polyneuropathy Two studies evaluating [...]

    Read Article
  • Visuel-EASD-Home-Event

    Diabetes / Events / News / Scientific publications

    EASD 2019 poster: diabetic foot risk detection with SUDOSCAN

    EASD 2019 POSTER:DIABETIC FOOT RISK DETECTION A multi-center study (3 [...]

    Read Article
Previous34

Subscribe to receive our scientific news

Name(Required)
Consent(Required)
  • Webinar
    Webinar : Clinical Experience of Sudoscan, Applications in Pain and Neurological Conditions – May the 15th 2025

    October 31, 2026

  • Events
    Sudoscan and Withings at the 2025 ATTD Conference in Amsterdam

    October 31, 2026

  • Events
    Sudoscan and Withings at the 2025 SFD Congress

    October 31, 2026

About Sudoscan

Sudoscan is a class IIa Medical device, Manufactured by Impeto Medical, indicated for early identification and follow-up of peripheral autonomic neuropathies.

For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark

Sudoscan in the world
  • Sudoscan International
  • Sudoscan USA
More information
  • Privacy policy
  • Cookies Policy
  • Subscribe to our Scientific News
Sudoscan Technology
  • Technology Principle
  • Evaluation of Sudomotor Function
  • Peripheral Neuropathy Detection
  • Sudoscan : a patented technology
Contact info
  • France HEADQUARTERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux

  • Phone: +33 (0)7 87 20 32 03
  • Sudoscan USA: 8525 Gibbs Dr Suite 304, San Diego, CA 92123, États-Unis
  • Phone: 858-450-2800

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Page load link

Innovations in Autonomic Function Testing

  • SUDOSCAN
    • About SUDOSCAN
    • FAQ
    • Cleaning Products
    • Patients Information
  • THERAPEUTIC AREAS
    • SUDOSCAN and Diabetes
    • SUDOSCAN in Neurology
    • SUDOSCAN in Oncology
    • SUDOSCAN in Nephrology
    • Follow-up with SUDOSCAN
    • Diabetes Risk with EZSCAN
  • SCIENCE & RESEARCH
    • SUDOSCAN Publications
    • Scientific references worldwide
    • Scientific news
    • Webinars & Replays
    • Join Clinical Research
    • Subscribe to our Scientific News
  • WHO WE ARE
    • About Impeto Medical
    • Impeto Medical in the World
  • REQUEST A DEMO
  • CONTACT US
  • NEWS & EVENTS
  • DISTRIBUTOR RESOURCES
Contact Info

France HEADQUATERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux

Phone: +33 (0)7 87 20 32 03

Discover SudoscanDiscover Sudoscan

Remote Patient Monitoring Revolution

Discover Sudocloud

Seamlessly connect, retrieve, and manage patient data with our secure and efficient cloud-based platform.

Read more about SUDOCLOUD
Go to Top